[EN] THIOPHENE DERIVATIVES FOR THE TREATMENT OF DISORDERS CAUSED BY IGE<br/>[FR] DÉRIVÉS DE THIOPHÈNE POUR LE TRAITEMENT DE TROUBLES PROVOQUÉS PAR IGE
申请人:UCB BIOPHARMA SRL
公开号:WO2019243550A1
公开(公告)日:2019-12-26
Thiophene derivatives of formula (I) and a pharmaceutically acceptable salt thereof are provided. These compounds have utility for the treatment or prevention of disorders caused by IgE, such as allergy, type 1 hypersensitivity or familiar sinus inflammation.
Compounds of formula I:
are useful in treating diseases prevented by or ameliorated with potassium channel openers. Also disclosed are potassium channel opening compositions and a method of opening potassium channels in a mammal.
[EN] THIENO-PYRIDINONE DERIVATIVES AS KINASE INHIBITORS<br/>[FR] UTILISATION DE DERIVES DE THIENO-PYRIDONONE COMME INHIBITEURS DE KINASES
申请人:CELLTECH R&D LTD
公开号:WO2005042540A1
公开(公告)日:2005-05-12
A series of thieno[2,3-b]pyridin-6(7H)-one derivatives, substituted in the 3-position by an arylcarbonyl or heteroarylcarbonyl moiety, being inhibitors of p38 MAP kinase, are accordingly of use in medicine, for example in the treatment and/or prevention of immune or inflammatory disorders.
[EN] MULTIFUNCTIONAL NITROXIDE DERIVATIVES AND USES THEREOF<br/>[FR] DÉRIVÉS DE NITROXYDE MULTIFONCTIONNELS ET LEURS UTILISATIONS
申请人:RADIKAL THERAPEUTICS INC
公开号:WO2012077108A1
公开(公告)日:2012-06-14
The present invention provides multifunctional nitroxide derivatives comprising a potassium channel opener and a reactive oxygen species (ROS) degradation catalyst that can act as an anti-oxidant, as well as pharmaceutical compositions comprising them. The multifunctional compounds and pharmaceutical compositions of the invention are useful for treatment of diseases, disorders or conditions associated with oxidative stress or endothelial dysfunction.
Thieno-pyridinone derivatives as kinase inhibitors
申请人:Alexander Peter Rikki
公开号:US20070078131A1
公开(公告)日:2007-04-05
A series of thieno[2,3-b]pyridin-6(7H)-one derivatives, substituted in the 3-position by an arylcarbonyl or heteroaryl-carbonyl moiety, being inhibitors of p38 MAP kinase, are accordingly of use in medicine, for example in the treatment and/or prevention of immune or inflammatory disorders.